Joel K. Annor‐Gyamfi

Statistics

Publications

Citations

146

H-Index

Active since

2018

Affiliations

Oklahoma State University(Current)

University of North Carolina at Chapel Hill

Joel K. Annor‐Gyamfi is an author at Oklahoma State University specializing in medicinal chemistry, synthetic medicinal chemistry, and heterocyclic chemistry.

ORCID

Publications per year

2018–2023

Publications

Small Molecule Inhibitors of the Bacterioferritin (BfrB)–Ferredoxin (Bfd) Complex Kill Biofilm-Embedded <i>Pseudomonas aeruginosa</i> Cells

Anabel Soldano, Huili Yao, Achala N. D. Punchi Hewage et al. · ACS Infectious Diseases · 2020 · 38 citations · Full text

Life Sciences, Biochemistry, Microbiology +15

Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving Neurodegeneration

David H. Drewry, Joel K. Annor‐Gyamfi, Carrow I. Wells et al. · Journal of Medicinal Chemistry · 2021 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Quinazolin-4(3H)-ones and 5,6-Dihydropyrimidin-4(3H)-ones from β-Aminoamides and Orthoesters

Joshua Gavin, Joel K. Annor‐Gyamfi, Richard A. Bunce · Molecules · 2018 · 20 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +6

4H-Benzo[d][1,3]oxazin-4-ones and Dihydro Analogs from Substituted Anthranilic Acids and Orthoesters

Joel K. Annor‐Gyamfi, Richard A. Bunce · Molecules · 2019 · 17 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +16

Synthesis and biological activity of fused tetracyclic Pyrrolo[2,1-c][1,4]benzodiazepines

Joel K. Annor‐Gyamfi, John M. Jarrett, Joseph Osamudiamen Osazee et al. · Heliyon · 2018 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 7